Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan

Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan - Real World Characterization of Patients with Advanced or Metastatic Liposarcoma in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053706

Enrollment

103

Registered

2024-02-26

Start date

2023-08-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or Metastatic Liposarcoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with a diagnosis of LPS. 2. Patients with a history of systemic antineoplastic therapy for LPS.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Progression-free survival (PFS) Overall survival (OS)	—

Secondary

Measure	Time frame
Overall response rate (ORR) Disease control rate (DCR)	—

Countries

Japan

Contacts

Public ContactYuichi Hirata

Nippon Boehringer Ingelheim Co., Ltd Oncology Pipeline Group, TA-Oncology Specialty Care Medicine

yuichi.hirata@boehringer-ingelheim.com03-6417-2200

Outcome results